Lauren Taylor, PA
Medical · Carson City, NVNPI 1447687884
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $240, 3.2 times the $75 reported in 2021. That places this record below the midpoint for medical clinicians in NV, where the typical reported total is $708.
Across 16 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$80
- Novo Nordisk$56
- Merck$49
- Abbott$47
- Boehringer Ingelheim$31
- VYNE Pharmaceuticals Inc.$30
- plus $46 from 3 others
What the payments were for
- Food & beverage$339100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 3 | $80 |
| Novo Nordisk | 3 | $56 |
| Merck | 2 | $49 |
| Abbott | 2 | $47 |
| Boehringer Ingelheim | 2 | $31 |
| VYNE Pharmaceuticals Inc. | 1 | $30 |
| LEO Pharma Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$339 in reported general payments places this provider in the 35th percentile of 250 medical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 19 | $282 |
| Atorvastatin Calcium | 47 | $282 |
| Amlodipine Besylate | 26 | $234 |
| Levothyroxine Sodium | 12 | $139 |
| Losartan Potassium | 17 | $135 |
| Fluticasone Propionate | 11 | $117 |
| Hydrochlorothiazide | 11 | $64 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other medical in Carson City
- McKenzie CombaCarson City$9K
- Danielle GrateCarson City$9K
- Ana TurnerCarson City$8K
- Kate McElroyCarson City$4K
- Jennifer McCordCarson City$3K
- John NotabartoloLas Vegas$284K
- Rachel BowersLas Vegas$29K
- Spencer MeierLas Vegas$24K
- Megan WieselLas Vegas$19K
- Tai PhamLas Vegas$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.